BK

Bal Kishan Agarwal

Active Director Director DIN 00702528
DIN 00702528 First appointment Jun 1995 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 1995
Shareholding value •••• Premium profile

About Bal Kishan Agarwal

Data last updated:

Bal Kishan Agarwal is a Director at Upraj Pharmaceuticals Private Limited (since 1995). The company operates in Chemicals. Upraj Pharmaceuticals Private Limited reported revenue of ₹32.4 Lakh (FY 2025).

DIN 00702528
Primary Designation Director
Industry Chemicals
First Appointment 15 Jun 1995
Oldest Company Age 31 yrs
Largest company Upraj Pharmaceuticals Private Limited · ₹32.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jun 19951995₹32.4 Lakh (FY 2025)Active

Board colleagues of Bal Kishan Agarwal

Directorship timeline

Open interactive timeline →
Upraj Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bal Kishan Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bal Kishan Agarwal

Bal Kishan Agarwal currently holds 1 directorship: Upraj Pharmaceuticals Private Limited (Director, since 15 Jun 1995, revenue ₹32.4 Lakh (FY 2025)).

Bal Kishan Agarwal was first appointed on 15 Jun 1995 as Director at Upraj Pharmaceuticals Private Limited.

The current boards of Bal Kishan Agarwal's companies include Shivam Agarwal (Upraj Pharmaceuticals Private Limited), Vinita Rani (Upraj Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available